Cargando…

Maternal heterozygosity of Slc6a19 causes metabolic perturbation and congenital NAD deficiency disorder in mice

Nicotinamide adenine dinucleotide (NAD) is a key metabolite synthesised from vitamin B3 or tryptophan. Disruption of genes encoding NAD synthesis enzymes reduces NAD levels and causes congenital NAD deficiency disorder (CNDD), characterised by multiple congenital malformations. SLC6A19 (encoding B(0...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuny, Hartmut, Bozon, Kayleigh, Kirk, Rosemary B., Sheng, Delicia Z., Bröer, Stefan, Dunwoodie, Sally L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Company of Biologists Ltd 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702539/ https://www.ncbi.nlm.nih.gov/pubmed/36374036 http://dx.doi.org/10.1242/dmm.049647

Ejemplares similares

Cells with loss-of-heterozygosity after exposure to ionizing radiation in Drosophila are culled by p53-dependent and p53-independent mechanisms
por: Brown, Jeremy, et al.
Publicado: (2020)

NAD+ deficiency in human congenital malformations and miscarriage: A new model of pleiotropy
por: Mark, Paul R.
Publicado: (2022)

ATP and NAD(+) Deficiency in Parkinson’s Disease
por: Mischley, Laurie K., et al.
Publicado: (2023)

Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis: A case series and literature review
por: van Dijk, Myrthe J., et al.
Publicado: (2022)

ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production
por: Masle-Farquhar, Etienne, et al.
Publicado: (2017)

SLC25A51 is a mammalian mitochondrial NAD(+) transporter
por: Luongo, Timothy S., et al.
Publicado: (2020)

MCART1/SLC25A51 is required for mitochondrial NAD transport
por: Kory, Nora, et al.
Publicado: (2020)

Maternal iron deficiency perturbs embryonic cardiovascular development in mice
por: Kalisch-Smith, Jacinta I., et al.
Publicado: (2021)

Compound Heterozygosity for Two Novel SLC26A4 Mutations in a Large Iranian Pedigree with Pendred Syndrome
por: Yazdanpanahi, Nasrin, et al.
Publicado: (2013)

Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays
por: Aleshin, Vasily A., et al.
Publicado: (2015)

SLC10A2 deficiency‐induced congenital chronic bile acid diarrhea and stunting
por: Qie, Di, et al.
Publicado: (2021)

Maternal Alcohol Dehydrogenase 1 Heterozygosity Drives Resistance of Offspring to Weight Gain
por: Chang, Allison, et al.
Publicado: (2022)

Epistasis-driven identification of SLC25A51 as a regulator of human mitochondrial NAD import
por: Girardi, Enrico, et al.
Publicado: (2020)

Welcome to the Family: Identification of the NAD(+) Transporter of Animal Mitochondria as Member of the Solute Carrier Family SLC25
por: Ziegler, Mathias, et al.
Publicado: (2021)

Inheritance of a paternal ABCC8 variant and maternal loss of heterozygosity at 11p15 retrospectively unmasks the etiology in a case of Congenital hyperinsulinism
por: Joyce, Caroline M., et al.
Publicado: (2020)

A new method to detect loss of heterozygosity using cohort heterozygosity comparisons
por: Green, Michael R, et al.
Publicado: (2010)

Assessment of Heterozygosity and Genome-Wide Analysis of Heterozygosity Regions in Two Duroc Pig Populations
por: Ruan, Donglin, et al.
Publicado: (2022)

Mitochondrial translation deficiency impairs NAD(+)‐mediated lysosomal acidification
por: Yagi, Mikako, et al.
Publicado: (2021)

Congenital Zinc Deficiency from Mutations of the SLC39A4 Gene as the Genetic Background of Acrodermatitis Enteropathica
por: Park, Chang-Hun, et al.
Publicado: (2010)

Combined Mutation Screening of NKX2-5, GATA4, and TBX5 in Congenital Heart Disease: Multiple Heterozygosity and Novel Mutations
por: Granados-Riveron, Javier T, et al.
Publicado: (2012)

Hepatocyte-specific perturbation of NAD(+) biosynthetic pathways in mice induces reversible nonalcoholic steatohepatitis–like phenotypes
por: Dall, Morten, et al.
Publicado: (2021)

Identification of SLC26A4 c.919-2A>G compound heterozygosity in hearing-impaired patients to improve genetic counseling
por: Li, Qi, et al.
Publicado: (2012)

Hepatic mitochondrial NAD(+) transporter SLC25A47 activates AMPKα mediating lipid metabolism and tumorigenesis
por: Cheng, Lili, et al.
Publicado: (2023)

Evaluation of loss of heterozygosity of chromosome 22q11.21 region in patients with congenital heart diseases
por: Behiry, Eman G., et al.
Publicado: (2018)

Loss of heterozygosity: what is it good for?
por: Ryland, Georgina L., et al.
Publicado: (2015)

Metabolic, Molecular, and Behavioral Effects of Western Diet in Serotonin Transporter-Deficient Mice: Rescue by Heterozygosity?
por: Veniaminova, Ekaterina, et al.
Publicado: (2020)

Vitamin B6 Deficiency Promotes Loss of Heterozygosity (LOH) at the Drosophila warts (wts) Locus
por: Gnocchini, Eleonora, et al.
Publicado: (2022)

SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
por: Lee, Jaewang, et al.
Publicado: (2022)

Nutritional Strategies to Counteract Mitochondrial Dysfunction and NAD+ Deficiency in Human Sarcopenia
por: Feige, Jerome
Publicado: (2020)

Recurrent exercise-induced acute renal failure in a young Pakistani man with severe renal hypouricemia and SLC2A9 compound heterozygosity
por: Jeannin, Guido, et al.
Publicado: (2014)

Absence of mitochondrial SLC25A51 enhances PARP1-dependent DNA repair by increasing nuclear NAD(+) levels
por: Güldenpfennig, Anka, et al.
Publicado: (2023)

Expression of Glutamine Transporter Slc38a3 (SNAT3) During Acidosis is Mediated by a Different Mechanism than Tissue-Specific Expression
por: Balkrishna, Sarojini, et al.
Publicado: (2014)

“NAD-capQ” detection and quantitation of NAD caps
por: Grudzien-Nogalska, Ewa, et al.
Publicado: (2018)

NBS1 Heterozygosity and Cancer Risk
por: di Masi, Alessandra, et al.
Publicado: (2008)

Loss of Heterozygosity and Its Importance in Evolution
por: Smukowski Heil, Caiti
Publicado: (2023)

Loss of heterozygosity as a marker of homologous repair deficiency in multiple myeloma: a role for PARP inhibition?
por: Pawlyn, Charlotte, et al.
Publicado: (2018)

Tirzepatide Therapy in a Patient with Type 2 Diabetes Mellitus, Chylomicronemia, and Heterozygosity for Lipoprotein Lipase Deficiency
por: Babirak, Stephan Paul
Publicado: (2023)

Metabolically distinct roles of NAD synthetase and NAD kinase define the essentiality of NAD and NADP in Mycobacterium tuberculosis
por: Sharma, Ritu, et al.
Publicado: (2023)

Cloning and Organelle Expression of Bamboo Mitochondrial Complex I Subunits Nad1, Nad2, Nad4, and Nad5 in the Yeast Saccharomyces cerevisiae
por: Tsai, Hsieh-Chin, et al.
Publicado: (2022)

Complementary NAD(+) replacement strategies fail to functionally protect dystrophin-deficient muscle
por: Frederick, David W., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u5voec44pkbtc5u9sqdgq2b2j4